A recent study indicated that a risk model generated by 5 cGAS-STING pathway-related genes (IFNB1, IFNA4, IL6, NFKB2, and TRIM25) could predict overall survival (OS) in patients with gastric cancer.[8] However, the prognostic values of cGAS-STING pathway-related genes in prostate adenocarcinoma (PRAD) are still unclear. This evidence concerns the gene CGAS and prostate adenocarcinoma.